PUBLISHER: The Business Research Company | PRODUCT CODE: 1945604
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945604
Microbiology diagnostics devices and equipment constitute a comprehensive category encompassing various items utilized in microbiology laboratories for the diagnosis of infectious diseases through the examination of pathogens. These devices and equipment include microscopes, slides, test tubes, Petri dishes, growth media (liquid and solid), inoculation loops, pipettes, tips, incubators, autoclaves, and laminar flow hoods. Some pieces of equipment, such as microscopes and hoods, are permanent fixtures, while others, such as pipette tips, are disposable.
The primary types of microbiology diagnostic devices and equipment comprise laboratory instruments, microbiology analyzers, and reagents and consumables. Laboratory instruments encompass items such as incubators, gram stainers, bacterial colony counters, petri dish fillers, and automated culture systems, which are essential for laboratory operations. Reagents include pathogen-specific kits and general reagents used across various end-users, including diagnostic laboratories, hospitals, and others.
Tariffs are impacting the microbiology diagnostic devices and equipment market by increasing costs of imported analyzers, microscopes, incubators, reagents, and laboratory consumables. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported laboratory equipment, while Asia-Pacific faces pricing pressure on consumable exports. These tariffs are increasing operational costs and procurement timelines. However, they are also encouraging domestic manufacturing of laboratory instruments, localized reagent production, and regional supply chain development for microbiology diagnostics.
The microbiology diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides microbiology diagnostic devices and equipment market statistics, including microbiology diagnostic devices and equipment industry global market size, regional shares, competitors with a microbiology diagnostic devices and equipment market share, detailed microbiology diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the microbiology diagnostic devices and equipment industry. This microbiology diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The microbiology diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $6.43 billion in 2025 to $7.5 billion in 2026 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to expansion of diagnostic laboratory infrastructure, rising incidence of infectious diseases, increased hospital-based testing volumes, improvements in laboratory automation technologies, wider availability of microbiology consumables.
The microbiology diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $11.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic testing, rising investments in laboratory automation, expansion of molecular and microbiology integration, growing focus on antimicrobial resistance detection, increasing adoption of point-of-care microbiology solutions. Major trends in the forecast period include increasing adoption of automated microbiology analyzers, rising demand for rapid pathogen detection solutions, growing use of high-throughput laboratory instruments, expansion of advanced culture and identification techniques, enhanced focus on laboratory workflow automation.
The increasing prevalence of noncommunicable diseases (NCDs) is anticipated to drive the expansion of the microbiology diagnostic devices and equipment market in the coming years. NCDs are health conditions that are not spread directly from one individual to another and include disorders such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes. The growing burden of NCDs is linked to complications that frequently necessitate laboratory-based microbiological testing to identify infections and monitor patient health. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, it was projected that by 2050, over 35 million new cancer cases would occur, reflecting a 77% rise compared to the estimated 20 million cases in 2022. Consequently, the increasing prevalence of noncommunicable diseases is fueling the growth of the microbiology diagnostic devices and equipment market.
Major companies in the microbiology diagnostic devices and equipment market are introducing innovative systems, such as third-generation total lab automation (TLA) systems, to enhance laboratory testing efficiency, accuracy, and cost-effectiveness. These advanced TLA systems automate various laboratory tasks, from specimen processing and plating to incubation, imaging, and culture reading. Becton, Dickinson, and Company (BD) launched third-generation TLA systems in January 2023, featuring a modular design, a robotic track system, advanced informatics solutions, and integration of artificial intelligence (AI). This system is customizable for a variety of tasks in a microbiology laboratory, making it a valuable tool for laboratories seeking improved efficiency, cost reduction, and enhanced patient care.
In May 2024, bioMerieux, a France-based producer of microbiology and molecular diagnostic systems, formed a partnership with Pfizer Inc. and the Malawi Ministry of Health to improve infectious disease management in Malawi. Through this collaboration, bioMerieux intends to strengthen the country's diagnostic, surveillance, and antimicrobial stewardship capabilities by utilizing its expertise in microbiology diagnostic devices and equipment. The initiative aims to increase testing capacity and support national efforts to address antimicrobial resistance (AMR). The Malawi Ministry of Health is a central government organization based in Malawi, and Pfizer Inc. is a US-based company focused on innovative medicines and vaccines.
Major companies operating in the microbiology diagnostic devices and equipment market are Danaher, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., Roche, Bruker Corporation, Merck KGaA, Siemens Healthcare, Beckman Coulter Inc., Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers, TestLine Clinical Diagnostics s.r.o., Cepheid, Hologic, Meridian Bioscience, Qiagen N.V., Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., PerkinElmer Inc., Neogen Corporation
North America was the largest region in the microbiology diagnostics devices and equipment market in 2025. Asia-Pacific was the second largest region in the global microbiology diagnostic devices and equipment market. The regions covered in the microbiology diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the microbiology diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The microbiology diagnostic devices and equipment consists of sales of instruments such as incubators, autoclave sterilizers, anaerobic culture systems, blood culture systems, gram strainers, microscopes, mass spectrometers, molecular diagnostic instruments, reagents pathogen-specific kits, and general reagents for microbiology diagnostic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microbiology Diagnostic Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses microbiology diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for microbiology diagnostic devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbiology diagnostic devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.